Capital International’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.6M | Sell |
70,183
-3,054
| -4% | -$3.1M | 2.39% | 7 |
|
|
2025
Q4 | $78.7M | Buy |
73,237
+4,497
| +7% | +$4.3M | 2.77% | 6 |
|
|
2025
Q3 | $52.4M | Sell |
68,740
-2,978
| -4% | -$2.22M | 1.9% | 10 |
|
|
2025
Q2 | $55.9M | Sell |
71,718
-657
| -0.9% | -$511K | 2.14% | 8 |
|
|
2025
Q1 | $59.8M | Buy |
72,375
+3,645
| +5% | +$3.03M | 2.61% | 7 |
|
|
2024
Q4 | $53.1M | Buy |
68,730
+2,015
| +3% | +$1.67M | 2.16% | 8 |
|
|
2024
Q3 | $59.1M | Sell |
66,715
-1,223
| -2% | -$1.1M | 2.55% | 6 |
|
|
2024
Q2 | $61.5M | Sell |
67,938
-4,525
| -6% | -$3.62M | 2.84% | 5 |
|
|
2024
Q1 | $56.4M | Sell |
72,463
-27,522
| -28% | -$19.6M | 2.7% | 4 |
|
|
2023
Q4 | $58.3M | Sell |
99,985
-2,100
| -2% | -$1.23M | 2.99% | 5 |
|
|
2023
Q3 | $54.8M | Sell |
102,085
-26
| -0% | -$13.4K | 3.15% | 5 |
|
|
2023
Q2 | $47.9M | Sell |
102,111
-4,304
| -4% | -$1.8M | 2.68% | 5 |
|
|
2023
Q1 | $36.5M | Buy |
106,415
+376
| +0.4% | +$127K | 2.19% | 5 |
|
|
2022
Q4 | $38.8M | Buy |
106,039
+818
| +0.8% | +$290K | 2.67% | 3 |
|
|
2022
Q3 | $34M | Buy |
105,221
+5,159
| +5% | +$1.63M | 2.37% | 5 |
|
|
2022
Q2 | $32.4M | Buy |
100,062
+50,586
| +102% | +$15.2M | 2.44% | 6 |
|
|
2022
Q1 | $14.2M | Buy |
49,476
+15,084
| +44% | +$3.88M | 0.81% | 31 |
|
|
2021
Q4 | $9.5M | Buy |
34,392
+6,355
| +23% | +$1.61M | 0.48% | 63 |
|
|
2021
Q3 | $6.48M | Sell |
28,037
-324
| -1% | -$80K | 0.35% | 79 |
|
|
2021
Q2 | $6.51M | Buy |
28,361
+61
| +0.2% | +$12.3K | 0.36% | 74 |
|
|
2021
Q1 | $5.29M | Buy |
+28,300
| New | +$5.54M | 0.32% | 92 |
|
|
2020
Q4 | – | Sell |
-9,025
| Closed | -$1.34M | – | 162 |
|
|
2020
Q3 | $1.34M | Buy |
9,025
+149
| +2% | +$23.1K | 0.09% | 136 |
|
|
2020
Q2 | $1.46M | Sell |
8,876
-12,517
| -59% | -$1.92M | 0.14% | 118 |
|
|
2020
Q1 | $2.97M | Sell |
21,393
-7,024
| -25% | -$965K | 0.33% | 76 |
|
|
2019
Q4 | $3.73M | Sell |
28,417
-15,866
| -36% | -$1.84M | 0.39% | 70 |
|
|
2019
Q3 | $4.95M | Buy |
44,283
+3,307
| +8% | +$368K | 0.75% | 38 |
|
|
2019
Q2 | $4.54M | Sell |
40,976
-2,574
| -6% | -$303K | 1.08% | 25 |
|
|
2019
Q1 | $5.65M | Buy |
43,550
+900
| +2% | +$109K | 1.35% | 18 |
|
|
2018
Q4 | $4.93M | Buy |
42,650
+27,000
| +173% | +$3.02M | 1.34% | 19 |
|
|
2018
Q3 | $1.68M | Sell |
15,650
-8,765
| -36% | -$876K | 0.52% | 56 |
|
|
2018
Q2 | $2.08M | Sell |
24,415
-300
| -1% | -$24.6K | 0.36% | 81 |
|
|
2018
Q1 | $1.91M | Buy |
24,715
+1,323
| +6% | +$107K | 0.34% | 85 |
|
|
2017
Q4 | $1.98M | Sell |
23,392
-9,365
| -29% | -$797K | 0.37% | 80 |
|
|
2017
Q3 | $2.8M | Hold |
32,757
| – | – | 0.18% | 84 |
|
|
2017
Q2 | $2.7M | Sell |
32,757
-800
| -2% | -$65.3K | 0.18% | 86 |
|
|
2017
Q1 | $2.82M | Sell |
33,557
-13,400
| -29% | -$1.07M | 0.18% | 86 |
|
|
2016
Q4 | $3.45M | Sell |
46,957
-122,543
| -72% | -$9.13M | 0.24% | 84 |
|
|
2016
Q3 | $13.6M | Sell |
169,500
-50,400
| -23% | -$4.03M | 0.96% | 40 |
|
|
2016
Q2 | $17.3M | Sell |
219,900
-109,800
| -33% | -$8.27M | 1.25% | 31 |
|
|
2016
Q1 | $23.7M | Buy |
329,700
+200
| +0.1% | +$15.1K | 1.53% | 19 |
|
|
2015
Q4 | $27.8M | Sell |
329,500
-23,300
| -7% | -$1.93M | 1.75% | 14 |
|
|
2015
Q3 | $29.5M | Buy |
352,800
+75,400
| +27% | +$6.37M | 1.96% | 12 |
|
|
2015
Q2 | $23.2M | Buy |
+277,400
| New | +$21.1M | 1.37% | 24 |
|
Other funds holding LLY
VCM
VPM
Capital International's LLY Position: Q1 2026 in Review
Capital International reduced its Eli Lilly (LLY) stake by 4.2% in Q1 2026, selling an estimated $3.1M and leaving 70,183 shares worth $64.6M. The position accounts for 2.39% of the portfolio, ranked #7.
Capital International first reported a position in LLY in Q2 2015 and has held it in 43 quarters since. The position peaked at $78.7M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Capital International held 70,183 shares of Eli Lilly worth $64.6M as of Q1 2026.
- Capital International sold 3,054 Eli Lilly shares in Q1 2026, an estimated $3.1M.
- Eli Lilly made up 2.39% of Capital International's portfolio in Q1 2026, its #7 holding.
- Capital International first reported a position in Eli Lilly in Q2 2015 and has held it in 43 quarters since.
- Capital International's Eli Lilly position peaked at $78.7M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.